Bankwell Financial Group, Inc.'s filings document the holding company's ownership of Bankwell Bank and recurring disclosures for a commercial banking issuer. Form 8-K reports furnish quarterly results of operations and financial condition, Regulation FD presentation materials, and trends in profitability, loan growth, deposits, funding costs, net interest margin, credit quality and SBA lending activity.
Definitive proxy materials cover annual meeting governance, director matters, executive compensation, equity awards and shareholder voting items. The filings also record the company's Connecticut incorporation, public-company identifiers, furnished earnings releases and exhibits used to report financial results and presentation materials.
Bankwell Financial Group director Lawrence B. Seidman reported indirect open‑market sales of a total of 10,000 shares of Bankwell Financial Group, Inc. common stock on February 23, 2026 through affiliated entities. The sales, at prices between $47.39 and $47.42 per share, were executed by Seidman and Associates, L.L.C., Seidman Investment Partnership, L.P., Seidman Investment Partnership II, L.P., LSBK06-08, L.L.C., Broad Park Investors, L.L.C., and Chewy Gooey Cookies, L.P. The filing also lists Seidman’s direct and deferred restricted stock holdings, including grants of 1,455, 1,800 and 1,600 shares scheduled to vest in annual installments through February 7, 2029.
Bankwell Financial Group director Kevin D. Leitao reported an open-market sale of 200 shares of common stock at $46.39 per share. After this sale, he directly held 500 shares. Additional reported holdings include restricted stock awards totaling 1,455 and 1,800 shares with multi-year vesting, plus 4,500 shares held indirectly through an IRA.
Bankwell Financial Group director Lawrence B. Seidman reported a series of indirect open-market purchases of Bankwell common stock on February 12, 2026 by entities he is associated with. These include buys such as 642 shares at $48.07 through Seidman and Associates, L.L.C. and 218 shares at $48.13 through Seidman Investment Partnership, L.P., along with smaller purchases by other affiliated LLCs and partnerships at prices around $48 per share.
Following these transactions, the filing lists significant indirect holdings in these entities, plus direct and deferred compensation holdings, including 4,151 shares held through a Deferred Compensation Plan and 17,346 shares held directly. The report also details multiple Bankwell restricted stock grants made between 2022 and 2026, with portions already vested and additional installments scheduled to vest annually through 2029 under the company’s stock plans.
Bankwell Financial Group CEO Christopher R. Gruseke reported several equity transactions in company stock. On February 9, 2026, he acquired 7,654 shares under the 2022 stock plan, split between time-vested restricted stock and performance-based restricted stock that may vest between 2027 and 2029 if goals are met. He also received and vested an additional 1,516 performance shares tied to 2023 and 2024 results. To cover tax obligations on a total of 11,265 vesting shares, he sold 5,056 shares in an open-market transaction at about $49.79 per share through a company-sponsored cashless program.
Bankwell Financial Group’s President and CBO Matt McNeill received new equity awards and sold shares to cover taxes. On February 9, 2026, he was granted 4,860 common shares at $0 under the 2022 stock plan. Half are time-based restricted stock, vesting in three annual installments starting February 7, 2027, and half are performance-based shares that may cliff vest on February 7, 2029 if goals are met.
He also received 1,143 shares that granted and vested the same day, tied to additional 2023–2024 performance shares. To cover tax liabilities on a total of 8,462 vested shares, 3,794 shares were sold through a company cashless program at about $49.83, leaving 45,019 directly held shares plus separate restricted and performance awards of 3,588 and 15,000 shares under the same 2022 plan.
Bankwell Financial Group EVP & Chief Risk Officer Steven H. Brunner reported stock-based compensation and related share sales on February 9, 2026. He received 1,558 common shares at $0 under the 2022 Stock Plan, split between time-vested restricted stock and performance-based restricted stock with vesting dates in 2027 and 2029, if goals are met. He was also granted and vested an additional 518 shares tied to 2023–2025 performance awards.
To cover tax liabilities on the vesting of 3,717 shares, 1,876 shares were withheld and sold through the company-sponsored cashless stock exercise program at an average price of about $49.85, within a reported range of $49.52–$50.26. Following these transactions, Brunner continued to hold several blocks of Bankwell common stock directly.
Bankwell Financial Group director Todd Lampert reported new stock awards. On February 9, 2026, he received 291 shares and 1,455 shares of restricted common stock at a price of $0 per share under the company’s stock plans, reflecting equity-based compensation grants.
The 291-share grant will fully vest on February 7, 2027. The 1,455-share grant will vest in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029. After these transactions, Lampert is shown as beneficially owning 15,866 shares directly, plus 8,608 shares in an IRA and 9,699 shares in his spouse’s IRA.
Bankwell Financial Group director Eric J. Dale received a grant of 1,455 shares of restricted common stock on February 9, 2026. The award was issued at a price of $0 per share under the 2022 Bankwell Financial Group, Inc. Stock Plan.
The restricted stock vests in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029. The Form 4 also lists Dale’s other holdings, including directly held common stock and 41,296 shares held indirectly through a Deferred Compensation Plan, along with prior restricted stock grants with multi‑year vesting schedules.
Bankwell Financial Group director Darryl Demos received a grant of 1,455 shares of restricted common stock on February 9, 2026. The award was granted at a price of $0 per share under the 2022 Stock Plan and is scheduled to vest in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029.
The Form 4 also shows Demos’ previously granted restricted stock awards, including 1,600 shares granted on December 30, 2022, 1,600 shares granted on December 29, 2023, and 1,800 shares granted on February 7, 2025, with portions of each already vested according to their multi-year schedules.
Bankwell Financial Group director Blake S. Drexler received a grant of 1,455 shares of restricted common stock on February 9, 2026 at $0 per share. These shares were issued under the 2022 Stock Plan and are scheduled to vest in three equal installments of 485 shares on February 7, 2027, February 7, 2028, and February 7, 2029.
In addition to this new award, he reports various existing direct and indirect holdings, including shares in an IRA/401(k), a deferred compensation plan, and 58,224 shares held by family members over which he exercises effective control. He also reports 160,861 directly held common shares.